These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8199097)

  • 1. Goserelin (Zoladex) versus danazol for endometriosis: the North American experience.
    Damario MA; Rock JA
    Br J Obstet Gynaecol; 1994 May; 101 Suppl 10():13-8. PubMed ID: 8199097
    [No Abstract]   [Full Text] [Related]  

  • 2. Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group.
    Rock JA; Truglia JA; Caplan RJ
    Obstet Gynecol; 1993 Aug; 82(2):198-205. PubMed ID: 8336864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Goserelin depot versus danazol in the treatment of endometriosis the Australian/New Zealand experience.
    Aust N Z J Obstet Gynaecol; 1996 Feb; 36(1):55-60. PubMed ID: 8775253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team.
    Shaw RW
    Fertil Steril; 1992 Aug; 58(2):265-72. PubMed ID: 1386029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Goserelin versus danazol in the treatment of endometriosis.
    Giorgino FL; Cetera C; de Laurentiis G
    Clin Exp Obstet Gynecol; 1991; 18(2):127-31. PubMed ID: 1833094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of danazol and goserelin on insulin and glucagon in non-obese women with endometriosis.
    Golland IM; Vaughan-Williams CA; Shalet SM; Laing I; Elstein M
    Acta Endocrinol (Copenh); 1990 Oct; 123(4):405-10. PubMed ID: 2146853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol.
    Lemay A; Brideau NA; Forest JC; Dodin S; Maheux R
    Clin Endocrinol (Oxf); 1991 Oct; 35(4):305-10. PubMed ID: 1836425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple polypoid endometriosis--a rare complication following withdrawal of gonadotrophin releasing hormone (GnRH) agonist for severe endometriosis: a case report.
    Othman NH; Othman MS; Ismail AN; Mohammad NZ; Ismail Z
    Aust N Z J Obstet Gynaecol; 1996 May; 36(2):216-8. PubMed ID: 8798320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis.
    Takaesu Y; Nishi H; Kojima J; Sasaki T; Nagamitsu Y; Kato R; Isaka K
    J Obstet Gynaecol Res; 2016 Sep; 42(9):1152-8. PubMed ID: 27225336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis.
    Stevenson JC; Lees B; Gardner R; Shaw RW
    Horm Res; 1989; 32 Suppl 1():161-3; discussion 164. PubMed ID: 2533148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nafarelin versus danazol in the treatment of endometriosis.
    Rolland R; van der Heijden PF
    Am J Obstet Gynecol; 1990 Feb; 162(2):586-8. PubMed ID: 2137976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Zoladex: new approaches to hormone therapy].
    Shparyk IaV
    Lik Sprava; 1996; (5-6):44-50. PubMed ID: 9377399
    [No Abstract]   [Full Text] [Related]  

  • 13. [Materials on the novel preparation Zoladex. 1 March 1995, Moscow, Russia].
    Akush Ginekol (Mosk); 1995; (5):Suppl: 9 p.. PubMed ID: 8579193
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of pelvic endometriosis with goserelin, an LHRH agonist].
    Ventruba P; Crha I; Müller P; Mlyncek M
    Ceska Gynekol; 1996 Feb; 61(1):11-6. PubMed ID: 8624587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factors.
    Crook D; Gardner R; Worthington M; Nolan J; Stevenson JC; Shaw RW
    Horm Res; 1989; 32 Suppl 1():157-60. PubMed ID: 2533147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis.
    Kiilholma P; Tuimala R; Kivinen S; Korhonen M; Hagman E
    Fertil Steril; 1995 Nov; 64(5):903-8. PubMed ID: 7589632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale in use of LHRH analogues in endometriosis.
    Shaw RW
    Horm Res; 1989; 32 Suppl 1():110-4. PubMed ID: 2533143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin.
    Kennedy SH; Starkey PM; Sargent IL; Hicks BR; Barlow DH
    Obstet Gynecol; 1990 Jun; 75(6):914-8. PubMed ID: 2140439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic management of endometriosis.
    Saltiel E; Garabedian-Ruffalo SM
    Clin Pharm; 1991 Jul; 10(7):518-31. PubMed ID: 1830521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy of endometriosis].
    Wenzl R; Jirecek S; Huber J
    Wien Med Wochenschr; 1999; 149(13):372-3, 376. PubMed ID: 10568019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.